About
Arsanis is a clinical-stage biotechnology company that discovers and develops antibody-based therapies aimed at treating infectious diseases and immune-related disorders.
Explore Arsanis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.